Skip to content

A Pilot Study of Optic Nerve Ultrasound Following Cardiopulmonary Bypass

A Pilot Study of Optic Nerve Ultrasound Following Cardiopulmonary Bypass

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03757312
Enrollment
14
Registered
2018-11-28
Start date
2019-04-24
Completion date
2020-01-16
Last updated
2021-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Defect, Congenital Heart Disease

Keywords

cardiopulmonary bypass

Brief summary

The purpose of the proposed study is to evaluate the incidence of subtle increases in intracranial pressure (ICP) following cardiopulmonary bypass (CPB) using optic nerve sheath diameter (ONSD), measured by non-invasive ultrasound. As direct measurements of ICP are not feasible following CPB, ONSD will be used as a correlate of ICP. ONSD has been shown to be effective in the ICU and emergency room setting for detecting increased ICP and is an accepted standard for such measurements. The primary hypothesis is that changes in ICP occur following CPB without clinically appreciable signs and symptoms. These changes in ICP will be reflected by changes in ONSD. If there is a significant incidence of sub-clinical cerebral edema and increased ICP postoperatively, these findings may impact postoperative hemodynamic and ventilation goals and techniques.

Interventions

DIAGNOSTIC_TESTUltrasound

Ocular ultrasound to measure optic nerve sheath diameter (ONSD).

Sponsors

Marco Corridore
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patients less than 18 years of age undergoing cardiac bypass.

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Optic Nerve Sheath DiameterDay of surgeryOptic nerve sheath diameter normal values: ≤4.0 mm for patients \<1 year and ≤4.5 mm used for patients ≥1 year of age, thus there is potential for worse outcomes with higher diameters.

Secondary

MeasureTime frameDescription
Optic Nerve Sheath Diameter: Short Versus Long Cardiopulmonary Bypass (CPB) TimeDay of surgeryShort CPB time defined as \<100 minutes. Long CPB time defined as ≥ 100 minutes.

Countries

United States

Participant flow

Participants by arm

ArmCount
Fontan
Patients undergoing Fontan procedure to redirect blood flow from the lower body to the lungs. Ultrasound: Ocular ultrasound to measure optic nerve sheath diameter (ONSD).
5
Non-Fontan
Patients undergoing other cardiac surgeries requiring cardiopulmonary bypass.
9
Total14

Baseline characteristics

CharacteristicFontanNon-FontanTotal
Age, Categorical
<=18 years
5 Participants9 Participants14 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous2.6 years1.3 years1.8 years
American Society of Anesthesiologists (ASA) status
ASA 3
0 Participants2 Participants2 Participants
American Society of Anesthesiologists (ASA) status
ASA 4
5 Participants7 Participants12 Participants
Height88.2 centimeters74.3 centimeters79.2 centimeters
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
5 participants9 participants14 participants
Sex: Female, Male
Female
3 Participants4 Participants7 Participants
Sex: Female, Male
Male
2 Participants5 Participants7 Participants
Weight13.5 kilograms9.3 kilograms10.8 kilograms

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 50 / 9
other
Total, other adverse events
0 / 50 / 9
serious
Total, serious adverse events
0 / 50 / 9

Outcome results

Primary

Optic Nerve Sheath Diameter

Optic nerve sheath diameter normal values: ≤4.0 mm for patients \<1 year and ≤4.5 mm used for patients ≥1 year of age, thus there is potential for worse outcomes with higher diameters.

Time frame: Day of surgery

ArmMeasureGroupValue (MEAN)
FontanOptic Nerve Sheath DiameterPost induction of anesthesia4.0 millimeters
FontanOptic Nerve Sheath DiameterAfter coming off of CPB4.2 millimeters
FontanOptic Nerve Sheath DiameterFollowing tracheal extubation in the OR4.2 millimeters
Non-FontanOptic Nerve Sheath DiameterPost induction of anesthesia3.6 millimeters
Non-FontanOptic Nerve Sheath DiameterAfter coming off of CPB3.5 millimeters
Non-FontanOptic Nerve Sheath DiameterFollowing tracheal extubation in the OR3.7 millimeters
Secondary

Optic Nerve Sheath Diameter: Short Versus Long Cardiopulmonary Bypass (CPB) Time

Short CPB time defined as \<100 minutes. Long CPB time defined as ≥ 100 minutes.

Time frame: Day of surgery

ArmMeasureGroupValue (MEAN)
FontanOptic Nerve Sheath Diameter: Short Versus Long Cardiopulmonary Bypass (CPB) TimePost-induction of anesthesia3.8 millimeters
FontanOptic Nerve Sheath Diameter: Short Versus Long Cardiopulmonary Bypass (CPB) TimeAfter coming off of CPB3.6 millimeters
FontanOptic Nerve Sheath Diameter: Short Versus Long Cardiopulmonary Bypass (CPB) TimeFollowing tracheal extubation in the OR3.8 millimeters
Non-FontanOptic Nerve Sheath Diameter: Short Versus Long Cardiopulmonary Bypass (CPB) TimePost-induction of anesthesia3.6 millimeters
Non-FontanOptic Nerve Sheath Diameter: Short Versus Long Cardiopulmonary Bypass (CPB) TimeAfter coming off of CPB3.8 millimeters
Non-FontanOptic Nerve Sheath Diameter: Short Versus Long Cardiopulmonary Bypass (CPB) TimeFollowing tracheal extubation in the OR3.8 millimeters

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026